Skip to main content
. 2024 Sep 24;13(18):e70242. doi: 10.1002/cam4.70242

FIGURE 7.

FIGURE 7

PGK1 is involved in promoting cisplatin resistance in bladder cancer (BLCA). (A, B) Cisplatin was added to T24 and J82 cells according to the concentration gradient to evaluate IC50. (C) IC50 was decreased after the knockdown of PGK1 in T24 cells. (D) IC50 was increased after overexpression of PGK1 in J82 cells.